The Colony Stimulating Factors Market is expected to grow at a 7.90% CAGR during the forecast period for 2024-2031. Colony stimulating factors (CSFs) are proteins that resemble hormones and encourage the development of immune cells that can fight infections. Human bodies manufacture CSFs from various cells, which can travel throughout the body and attach to cells with specific CSF receptors. CSFs can stimulate the synthesis of immune cel...
Report ID: 1382 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 190
PARP Inhibitor Biomarkers Market Size is valued at USD 897.8 Mn in 2023 and is predicted to reach USD 1,751.6 Mn by the year 2031 at a 8.8% CAGR during the forecast period for 2024-2031. These biomarkers play a critical role in informing treatment decisions and identifying patients who are at the highest risk of benefiting from PARP inhibitor therapy. In order to detect these markers, genomic profiling or specific genetic assays are frequently...
Report ID: 2447 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 178
The Global Organic Feminine Care Market Size is valued at 2.43 billion in 2022 and is predicted to reach 3.87 billion by the year 2031 at a 5.57% CAGR during the forecast period for 2023-2031. Menstrual pads, tampons, and natural cotton pants liners are among the organic feminine care items, sometimes known as women's or cotton cleanliness items. Due to the natural cotton content, these feminine care products are disposable and biodegradable. ...
Report ID: 1734 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 180
Molecular Beam Epitaxy Market Size is valued at USD 97.6 million in 2023 and is predicted to reach USD 188.2 million by the year 2031 at an 8.7% CAGR during the forecast period for 2024-2031. Molecular beam epitaxy (MBE) allows for the precise and controlled deposition of tiny portions of numerous substances at anatomical levels on a supporting material. For the creation of superior crystallized films, it is extensively used in nanomaterials r...
Report ID: 2768 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 180
Breast Cancer Core Needle Biopsy Market Size is valued at USD 697.3 Mn in 2023 and is predicted to reach USD 1,042.3 Mn by the year 2031 at a 5.34% CAGR during the forecast period for 2024-2031. A biopsy is a confirmatory procedure that helps in early cancer/tumour diagnosis, resulting in faster recovery, higher survival rates, and lower rates of morbidity and mortality. A Breast Cancer Core Needle Biopsy is a less invasive alternative to surg...
Report ID: 2310 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 179
Clinical Biomarkers Market Size is valued at USD 25.02 Bn in 2023 and is predicted to reach USD 47.25 Bn by the year 2031 at a 8.54% CAGR during the forecast period for 2024-2031. Clinical biomarkers are molecular biomarkers that offer novel avenues for studying diseases and identifying potential new therapeutic targets. Clinical biomarkers are finding more and more applications in drug development, disease risk assessment, and other areas, an...
Report ID: 2324 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 179
The Deep Vein Thrombosis Market Size is valued at 958.11 Million in 2022 and is predicted to reach 1343.86 Million by the year 2031 at a 4.0 % CAGR during the forecast period for 2023-2031. Deep vein thrombosis (DVT) is a serious condition that occurs when clots forms in the deep veins of the body. The most dangerous complication of deep vein thrombosis is pulmonary embolism (PE), which can either be asymptomatic or symptomatic. Surgery and pr...
Report ID: 1070 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 180
Erdosteine Market Size is valued at USD 147.21 Mn in 2022 and is predicted to reach USD 301.61 Mn by the year 2031 at a 8.45% CAGR during the forecast period for 2023-2031. The changing environment, including increased air pollution and cigarette or tobacco smoking, has resulted in an increase in respiratory disorders and ailments. Prolonged exposure to chemicals in industrial units, as well as indoor pollution in rural areas, leads to the inc...
Report ID: 2128 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 179
Vegetable Capsules Market Size is valued at USD 1.45 Bn in 2023 and is predicted to reach USD 3.03 Bn by the year 2031 at a 9.7% CAGR during the forecast period for 2024-2031. Vegetable capsules serve as substitutes for conventional gelatin capsules and are often composed of hydroxypropyl methylcellulose (HPMC), which is obtained from cellulose or other plant sources such as pullulan. They are highly sought after in the pharmaceutical and nutr...
Report ID: 2465 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 180
Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market Size is valued at 21.1 Bn in 2023 and is predicted to reach 31.4 Bn by the year 2031 at an 5.3% CAGR during the forecast period for 2024-2031. Premenstrual Syndrome (PMS) is a widespread condition impacting millions of women globally. It is marked by a spectrum of physical and emotional symptoms occurring in the days preceding menstruation. These symptoms can vary from mild to...
Report ID: 2518 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 180
Pharmaceuticals